Europe Metastatic Cancer Drugs Market

Europe Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-16553 Publication Date: July-2023 Number of Pages: 149
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 Europe Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 2 Europe Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Metastatic Cancer Drugs Market
TABLE 4 Product Launches And Product Expansions– Metastatic Cancer Drugs Market
TABLE 5 Acquisition and Mergers– Metastatic Cancer Drugs Market
TABLE 6 Approvals & Trials– Metastatic Cancer Drugs Market
TABLE 7 Europe Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 8 Europe Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 9 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 16 Europe Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 17 Europe Breast Cancer Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Breast Cancer Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Lung Cancer Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Lung Cancer Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Colorectal Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Colorectal Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Melanoma & Others Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Melanoma & Others Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 28 Europe Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 29 Europe Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Immunotherapy Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Immunotherapy Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Hormonal Therapy Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Hormonal Therapy Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 37 Europe Metastatic Cancer Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe Metastatic Cancer Drugs Market by Country, 2023 - 2030, USD Million
TABLE 39 Germany Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 40 Germany Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 41 Germany Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Germany Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Germany Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 44 Germany Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 45 Germany Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 46 Germany Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 47 UK Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 48 UK Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 49 UK Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 UK Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 UK Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 52 UK Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 53 UK Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 54 UK Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 55 France Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 56 France Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 57 France Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 France Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 France Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 60 France Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 61 France Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 62 France Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 63 Russia Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 64 Russia Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 65 Russia Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Russia Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Russia Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 68 Russia Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 69 Russia Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 70 Russia Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 71 Spain Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 72 Spain Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 73 Spain Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Spain Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Spain Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 76 Spain Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 77 Spain Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 78 Spain Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 79 Italy Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 80 Italy Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 81 Italy Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Italy Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Italy Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 84 Italy Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 85 Italy Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 86 Italy Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 87 Rest of Europe Metastatic Cancer Drugs Market, 2019 - 2022, USD Million
TABLE 88 Rest of Europe Metastatic Cancer Drugs Market, 2023 - 2030, USD Million
TABLE 89 Rest of Europe Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Rest of Europe Metastatic Cancer Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 91 Rest of Europe Metastatic Cancer Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 92 Rest of Europe Metastatic Cancer Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 93 Rest of Europe Metastatic Cancer Drugs Market by Therapy, 2019 - 2022, USD Million
TABLE 94 Rest of Europe Metastatic Cancer Drugs Market by Therapy, 2023 - 2030, USD Million
TABLE 95 Key Information – Bristol Myers Squibb Company
TABLE 96 KEY INFORMATION - Merck & Co., Inc.
TABLE 97 KEY INFORMATION – AstraZeneca PLC
TABLE 98 Key Information – Novartis AG
TABLE 99 Key Information – Eli Lilly And Company
TABLE 100 Key Information – Pfizer, Inc.
TABLE 101 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 102 Key Information – Johnson & Johnson
TABLE 103 Key Information – Amgen, Inc.
TABLE 104 Key Information – Sanofi S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Metastatic Cancer Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Metastatic Cancer Drugs Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2019, Jul – 2023, Apr) Leading Players
FIG 7 Porter’s Five Forces Analysis - Metastatic Cancer Drugs Market
FIG 8 Europe Metastatic Cancer Drugs Market share by Distribution Channel, 2022
FIG 9 Europe Metastatic Cancer Drugs Market share by Distribution Channel, 2030
FIG 10 Europe Metastatic Cancer Drugs Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 Europe Metastatic Cancer Drugs Market share by Indication, 2022
FIG 12 Europe Metastatic Cancer Drugs Market share by Indication, 2030
FIG 13 Europe Metastatic Cancer Drugs Market by Indication, 2019 - 2030, USD Million
FIG 14 Europe Metastatic Cancer Drugs Market share by Therapy, 2019
FIG 15 Europe Metastatic Cancer Drugs Market share by Therapy, 2030
FIG 16 Europe Metastatic Cancer Drugs Market by Therapy, 2019 - 2030, USD Million
FIG 17 Europe Metastatic Cancer Drugs Market share by Country, 2022
FIG 18 Europe Metastatic Cancer Drugs Market share by Country, 2030
FIG 19 Europe Metastatic Cancer Drugs Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Bristol Myers Squibb Company
FIG 21 Swot Analysis: Merck & Co., Inc.
FIG 22 Swot Analysis: AstraZeneca PLC
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Swot Analysis: Eli Lilly And Company
FIG 25 Recent strategies and developments: Pfizer, Inc.
FIG 26 Swot Analysis: Pfizer, Inc.
FIG 27 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 28 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 29 Swot Analysis: Johnson & Johnson
FIG 30 Swot Analysis: Amgen, Inc.
FIG 31 Swot Analysis: Sanofi S.A.
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo